Xinrui Regeneration
Latest round
- Angel
Last raised
- May 2019
Total raised
- Undisclosed
Investors
- 1
About Xinrui Regeneration
Based in Nanjing, China, and established in 2019, Xinrui Regeneration is a biology company that focuses on innovative drug development. The founding team and core members come from Peking University, Tsinghua University, Fudan University, and other universities, and have decades of research and industrial experience in the fields of stem cells and regenerative medicine, artificial intelligence, and drug discovery and development. The founder and Chief Scientist Officer, Yang Zhao is a researcher and doctoral director at the Institute of Molecular Medicine, Peking University Institute of Future Technology. In December 2022, Suzhou Huace Bio reached a partnership with the company. The company is committed to developing innovative drugs for in situ tissue and organ regeneration, fibrosis reversal, and tumor cell reprogramming. It has built a small molecule drug discovery platform CReDIT (Cell Revitalizing Drug Innovation Technology) based on cell reprogramming technology, high-throughput genomics, and artificial intelligence. The technical services include the phenotype evaluation technology platform, disease cell model construction technology platform, and compound services. It also provides Swift CellSignature High-Throughput RNA extraction Kit, 96-well side magnetic rack, and other products. The company generates revenue by developing innovative drugs.
Who invested in Xinrui Regeneration
1 investor across 1 round
See all investors in Xinrui Regeneration
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 29, 2019
Amount
Undisclosed
Investors
Questions about Xinrui Regeneration
Who invested in Xinrui Regeneration?
Xinrui Regeneration has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xinrui Regeneration raised?
Xinrui Regeneration has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xinrui Regeneration last raise money?
Xinrui Regeneration's most recent round on record is a Angel, in May 2019.
What does Xinrui Regeneration do?
Based in Nanjing, China, and established in 2019, Xinrui Regeneration is a biology company that focuses on innovative drug development.
Where is Xinrui Regeneration headquartered?
Xinrui Regeneration is headquartered in Nanjing, China.
Which VCs invest in companies like Xinrui Regeneration?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Xinrui Regeneration's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Xinrui Regeneration? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.